drugset / Trial / NCT05006417

Botox for the Treatment of Recurrent Chronic Exertional Compartment Syndrome

NCT05006417 ↗

Phase 4 Terminated 1 enrolled University of Wisconsin, Madison
NaSingle-groupOpen-labelTreatment

Summary

10 participants with Recurrent Chronic Exertional Compartment Syndrome (R-CECS) will be enrolled in a 6 month study at the University of Wisconsin Hospitals and Clinics to test the hypothesis that injection of Botox into the affected muscle group will alleviate pain associated with R-CECS.

Timeline

Start
2022-11-23
Primary completion
2022-11-23
Completion
2022-11-23

Outcome

Outcome not reported

Stopped (Business): “issues with supplier of strength testing equipment, presumed to go out of business”

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic — —

Indications